Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA · BSE: 524715 · Pharmaceuticals & Biotechnology · 54 announcements

Share price: ₹1,781.00
Market cap: ₹4,27,322 Cr
Revenue (annual): ₹58,462 Cr
Net profit (annual): ₹11,479 Cr
P/E (TTM): 35.3×Sector 47.4×
Promoter holding: 54.48%+0.00% QoQ
FII holding: 14.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

10 Apr 2026 16:08 IST NSE

Sun Pharmaceutical Industries Price Movement Clarification

Sun Pharmaceutical Industries clarified that news regarding a potential $12 billion deal with Organon is speculative. The company stated there is no material information requiring disclosure under Regulation 30. Sun Pharma maintains high governance standards and will inform exchanges of any future material events as required.

Value: ₹1,104 Cr

Read the filing ↗